Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Alexion Pharmaceuticals
(NQ:
ALXN
)
159.73
USD
+1.87 (+1.18%)
Official Closing Price
Updated: 7:59 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Alexion Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
ALEXION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alexion Pharmaceuticals, Inc. - ALXN
January 22, 2021
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Alexion Pharmaceuticals, Inc. (NasdaqGS: ALXN)...
From
Business Wire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds NPA, THBR, GIX, and ALXN Shareholders About Its Ongoing Investigations
January 22, 2021
From
PR Newswire
ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - CHNG, OXFD, SMTX, OBLN, ALXN, BYFC, CIT
January 22, 2021
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
From
PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ALXN, CHNG, RP, RNET, MDCA, NK; Shareholders Are Encouraged to Contact the Firm
January 14, 2021
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
From
PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds MTSC, IPHI, ALXN and XLNX Shareholders About Its Ongoing Investigations
January 13, 2021
From
PR Newswire
Alexion Provides Update on Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19
January 13, 2021
Alexion Provides Update on Phase 3 Study of ULTOMIRIS® (ravulizumab) in Hospitalized Patients with Severe COVID-19
From
Business Wire News Releases
Alexion Highlights Commercial, Clinical and Financial Progress at the 39th Annual J.P. Morgan Healthcare Conference
January 12, 2021
Alexion Highlights Commercial, Clinical and Financial Progress at the 39th Annual J.P. Morgan Healthcare Conference
From
Business Wire News Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ALXN, MGLN, FLIR, BEAT; Shareholders Are Encouraged to Contact the Firm
January 07, 2021
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, IPHI, ALXN, and XLNX Shareholders About Its Ongoing Investigations
January 06, 2021
From
PR Newswire
Alexion to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021
Alexion to Present at the 39th Annual J.P. Morgan Healthcare Conference
From
Business Wire News Releases
ALERT: Halper Sadeh LLP Investigates ALXN, SPWH, CBMG, STND, EIDX; Shareholders Are Encouraged to Contact the Firm
January 05, 2021
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
From
PR Newswire
MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages RP, MDCA, ALXN, SPWH Shareholders to Contact the Firm
January 01, 2021
From
GlobeNewswire News Releases
WeissLaw LLP Reminds MTSC, EIDX, IPHI, and ALXN Shareholders About Its Ongoing Investigations
December 30, 2020
From
PR Newswire
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers - ALXN, TCF, CATM, TCP
December 24, 2020
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
From
PR Newswire
Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm – PNM, ALXN, HMSY
December 23, 2020
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds TCF and ALXN Shareholders About Its Ongoing Investigations
December 21, 2020
From
PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Alexion Pharmaceuticals, Inc. - ALXN
December 18, 2020
From
PR Newswire
ALEXION INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alexion Pharmaceuticals, Inc. - ALXN
December 16, 2020
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Alexion Pharmaceuticals, Inc. (NasdaqGS: ALXN)...
From
PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - ALXN, CATM, TCP, PRVL
December 16, 2020
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
From
PR Newswire
ALEXION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ALXN and Encourages Investors to Contact the Firm
December 15, 2020
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – ALXN, PS, HBAN, CKH
December 15, 2020
From
GlobeNewswire News Releases
Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
December 15, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods
December 15, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Alexion Pharmaceuticals, Inc. Buyout
December 14, 2020
From
GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Investigates Alexion Pharmaceuticals, Inc.
December 14, 2020
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (NASDAQ: ALXN) in...
From
PR Newswire
Thinking about buying stock in Pfizer, Moderna, Arvinas, Veru, or Alexion Pharmaceuticals?
December 14, 2020
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, ARVN, VERU, and ALXN.
From
PR Newswire
(ALXN): Johnson Fistel Investigates Proposed Sale of Alexion Pharmaceuticals; Are Shareholders Getting a Fair Deal?
December 13, 2020
Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (NASDAQ: ALXN) breached their...
From
PR Newswire
Alexion Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Alexion Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AL
December 12, 2020
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) to AstraZeneca PLC for $60.00 in cash and 2.1243 AstraZeneca...
From
Business Wire News Releases
AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development
December 12, 2020
AstraZeneca to acquire Alexion, accelerating the Company's strategic and financial development
From
Business Wire News Releases
Alexion Receives Marketing Authorization from European Commission for New Formulation of ULTOMIRIS® (ravulizumab) with Significantly Reduced Infusion Time
November 20, 2020
Marketing Authorization from European Commission for New Formulation of ULTOMIRIS® (ravulizumab) with Significantly Reduced Infusion Time
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.